http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2368396-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-00 |
| filingDate | 2008-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee4c0f17899279437bc2851a1c88e2f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65dd35411c2218bd6484a8e2852f541e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b258712652004471e70849f2d3fe8574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b35be71f0b7415f3d3ea42dadcbcac5a |
| publicationDate | 2009-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2368396-C1 |
| titleOfInvention | Correction method of diuretic-resistant ascites at liver cirrhosis |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine and namely to surgery. Ascitic fluid is taken from abdominal space and reinfused to venous bed. Reinfusion is performed till complete regress and arresting of ascites against conservative therapy. Ascitic fluid is taken and reinfused through fully implantable peritoneal port-system. That latter is installed in hypoderm. Cannula of the port-system is introduced into the abdominal space. The working end of cannula is installed in iliac fossa. Cannula is implanted to straight muscle behind the cuff. Cannula is connected to the port. Transfusion system led through an infusomate is connected to the port-system. Venous end of the transfusion system is connected to subclavian vein. Ascitic fluid is reinfused every day at the speed of 15-20 ml per minute, in parts of 500-700 ml with an interval of 5-7 min. Reinfusion volume is 1.5-2.5 l with decrease of the volume up to 1.05-55 l. n EFFECT: method allows enlarging correction range irrespective of abdominal pressure, central hemodynamics and rheology of ascitic content, prevents bleeding syndrome owing to preventing hemodilution and coagulopathy due to the fact that ascitic reinfusion is performed in parts. n 2 ex |
| priorityDate | 2008-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.